Latest1 information on COVID-19
©2022 Stanford Medicine
Not Recruiting
Trial ID: NCT04296266
Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery
Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Professor, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Inclusion Criteria:
- Elected to undergo surgery for recent diagnosis of parotid or submandibular gland
tumor
- Ability to adhere to study visit schedule and other protocol requirements
- Operable candidate base on the surgeon's note
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Nursing or pregnant
- Diagnosis of kidney disease, history of renal disease with creatinine > 1.5 mg/dL, or
currently on dialysis
- Diagnosis of end stage liver disease
- Any unstable medical condition
- Use of chemotherapy or radiotherapy within 4 weeks before first dose of study dietary
supplement
- Unwilling to stop dietary supplements 3 weeks before first dose of study dietary
supplement
drug: Alda-341
Not Recruiting
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305